Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2

Journal of Alzheimer's Disease

Volumn 3, Issue 4, 2001, Pages 417-425

  Galvan M ^a   David, J P ^b   Delacourte, A ^b   Luna, J ^a   Mena, R ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSERM   (France)

Author keywords

AD2; Alzheimer disease; Confocal microscopy; Hippocampus; Hyperphosphorylated tau protein; Neurofibrillary tangles

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AD2; TAU ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ANTIBODY DETECTION; ANTIBODY LABELING; ARTICLE; BRAIN DEGENERATION; CELL DENSITY; CELL LABELING; CLINICAL ARTICLE; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MORPHOMETRICS; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034843039     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2001-3409     Document Type: Article

References (38)

1. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
2. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease
3. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease
4. Regulated phosphorylation and dephosphorylation of tau protein: Efects on microtubule interaction, intracellular trafficking and neurodegeneration
5. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
6. Neuropathological staging of Alzheimer-related changes
7. Production of paired helical filament, Tau-like proteins by PC12 cells: A model of neurofibrillary degeneration
8. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease
9. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease: An immunohistochemical study
10. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
11. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease
12. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein crosslinking in Alzheimer disease
13. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments
14. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
15. Correlations of synaptic and pathological markers with cognition of the elderly
16. Modeling the relation between neurofibrillary tangles and intellectual status
17. Microtubule- associated proteins tau and amyloid P component in Alzheimer's disease
18. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease
19. Tau phosphorylation at Ser-396 and Ser-404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly
20. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old
21. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrilary pathology in Alzheimer's disease
22. Tau-proteins of Alzheimer paired helical filaments-abnormal phosphorylation of all six brain isoforms
23. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
24. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
25. Abnormal phosphorylation of the Map tau in Alzheimer cytoskeletal pathology
26. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia-regional and laminar distribution of neurofibrillary tangles and senile plaques
27. A new clinical scale for the staging of dementia
28. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments
29. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease
30. Monitoring pathological assembly of tau and β-amyloid proteins in Alzheimer's disease
31. Proline-directed and non-proline-directed phosphorylation of PHF-tau
32. Hyperphosphorylation of tau in PHF
33. Posttranslational modifications of tau in paired helical filaments
34. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
35. Immunogold labeling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies
36. Design and synthesis of a potential affinity/cleaving reagent for beta-pleated sheet prorein structures
37. Ultrastructural localization of β-amyloid, τ, and ubiquitin epitopes in extracellular neurofibrillary tangles
38. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation